CUV 1.42% $13.90 clinuvel pharmaceuticals limited

5. data and comments. 5, page-64

  1. 158 Posts.
    re: 5. half year report. 5 Hi Stolly

    Glad to post here rather that the `graveyard'- the LUM thread. I guess that `near enough is good enough' as far as the PMLE study is concerned with dosage. All they need to do is Zap the subjects while they are still pale, brown them up and then Zap them again- so perhaps the trail may be finished in 2-3 months, and they will proceed with an `interim' implant just to get this trail going. Hope so.

    MB
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.